s h kelkar & co. - stock broking companies, share brokers · pdf file ·...
TRANSCRIPT
October 28, 2015
Prabhudas Lilladher Pvt. Ltd. and/or its associates (the 'Firm') does and/or seeks to do business with companies covered in its research reports. As a result investors should be aware that the Firm may have a conflict of interest that could affect the objectivity of the report. Investors should consider this report as only a single factor in making their investment decision.
Please refer to important disclosures and disclaimers at the end of the report
S H Kelkar & Co.
The perfumer arrives
IPO
No
te
Nishna Biyani [email protected] +91-22-66322239
Keyur Pandya [email protected] +91-22-66322247
Rating Subscribe
Price Band Rs173-Rs180
IPO Grading NA
(Grade 5/5 indicates strong fundamentals and
grade 1/5 indicates poor fundamentals)
IPO Fact Sheet
Opening Date October 28, 2015
Closing Date October 30, 2015
BRLMs JM Financial Institutional Securities Ltd,
Kotak Mahindra Capital Co Ltd
Issue Size Rs5.1bn
Fresh Issue Rs2.1bn
Offer for Sale (Blackstone/Promoters) Rs 3bn
Objects of the Issue
Repayment/Pre-payment of debt Rs 1.3bn
Repayment/Pre-payment of debt for K.V.Archem Pvt Ltd (100% subsidiary) Rs 0.3bn
General Corporate Purpose Rs 0.5bn
Issue Details Pre-issue equity (m shares) 133.0
Post-issue equity (m shares)* 144.6
Post-issue Market Cap (Rs bn)* 26.0
Share Holding (%) Pre-IssuePost-Issue*
Promoters 64.2 56.7
Public & Others 35.8 43.3
*Equity issuance calculated on higher band price
SH Kelkar & Co is India’s oldest and most renowned manufacturer and supplier of Fragrance & Flavours (F&F). The company commands a market share of ~20% in the fragrance industry (~size Rs23bn growing @10%) catering to more than 3700 customers across India. The fact that they are at a relative low market share of ~2% in the flavours industry (~size Rs18.7bn growing @10%) where it caters to more than 400 customers offers higher scope for growth. In addition, favourable industry dynamics and low capacity utilization of less than 40% bodes well for healthy growth rates for SH Kelkar over the next few years. The IPO valuation of Rs26bn may look expensive on FY15 valuations, which was as a result of one off aberration due to spike in prices of certain raw materials in FY15. With a strong growth and improving capacity utilisations over the next few years, we expect to see the margins to increase and earnings grow steadily, making the stock an attractive buy in the IPO. Considering factors such as quality management, high business entry barriers, no Indian listed play in the F&F segment, limited equity offering and strong co-relation with Indian consumer segment, we feel SH Kelkar is a portfolio stock and recommend “Subscribe” for the long term.
Key Highlights
Large expansion over, time for utilization to pick-up: SH Kelkar has added assets worth Rs2.15bn over FY11-FY15 period funded by internal accruals and Equity. This expansion has set the stage for growth in the next five years.
Strong business execution and experienced management: SH Kelkar’s financial performance has been robust, with revenue and earnings CAGR of 16.2% and 19.6%, respectively, over FY11-15 period. Further, the management team is very experienced, forward looking and is actively involved in day-to-day functions.
Debt free company post IPO, significant interest cost saving to accrue: Major parts of IPO proceeds (Rs2.1bn) are going to be utilized in retiring debt. This shall save finance cost of almost Rs190m a year.
Presence of strong in-house R&D team: SH Kelkar has a dedicated team of 18 scientists operating at its facilities in Mumbai and Netherlands. This team has developed 12 molecules over the past three years. It also has a team of 12 perfumers and 2 flavourists which helped it develop 502 new F&F compounds in FY15.
Key financials (Y/e March) FY12 FY13 FY14 FY15
Revenues (Rs m) 5,700 6,662 7,614 8,370
Growth (%) 24.0 16.9 14.3 9.9
EBITDA (Rs m) 1,044 1,180 1,370 1,193
PAT (Rs m) 412 616 791 644
Growth (%) 30.8 49.5 28.5 (18.6)
EPS (Rs)* 3.1 4.6 6.0 4.8
Profitability & Valuation FY12 FY13 FY14 FY15
EBITDA margin (%) 18.3 17.7 18.0 14.3
RoE (%) 13.7 15.4 17.5 13.0
RoCE (%) 11.3 11.8 13.8 8.6
PE (x) 58.1 38.9 30.2 37.2
P / BV (x) 6.4 5.6 5.0 4.7
Source: Company Data; PL Research * Historic EPS calculated on 133m shares outstanding
October 28, 2015 2
S H Kelkar & Co.
Exhibit 1: Issue details
Issue Period Opening date: 28th October 2015; Closing date: 30th October 2015
Exchange Listing on both NSE and BSE
Issuer S H Kelkar and Company Ltd
Offer Type Initial Public Offering
Offer Size including OFS Total 28.2 Million Equity Shares
Face Value Rs.10/-
Price Band Rs173 -180/ share
Bid Lot 80 equity shares and in multiples thereof
Issue Split (No. of shares)
QIB Portion: 50% of the issue
Non-Institutional portion: Not less than 15% of the issue
Retail Portion: Not less than 35% of the issue
Current Shareholding
Pre-Offer Post-Offer*
Promoters 64.2% 56.7%
Others 35.8 % 43.3%
Book Running Lead manager
JM Financial Institutional Securities Ltd, Kotak Mahindra Capital Company Ltd
Source: RHP *Equity issuance calculated on higher price band
Exhibit 2: Issue is priced between Rs25.1bn to Rs26.0bn MCap
Existing Outstanding Equity Shares (M) 133.0 133.0
Amount proposed to be raised (Rs M) 2100 2100
Price Band (Rs) 173 180
Fresh Issue (M) 12.1 11.7
Post Issue Shares Outstanding (M) 145.1 144.6
Post Issue Mcap band (Rs M) 25,101 26,032
Source: RHP
Exhibit 3: Utilization of Net Proceeds (Rs m)
Utilization of Net Proceeds Total Estimated Utilization
FY16E FY17E FY18E
Debt Repayment 1,580 1,360 100 100
General corporate purposes 520 520
Total 2,100 1,880 100 100
Source: RHP
October 28, 2015 3
S H Kelkar & Co.
Company Background
Incorporated in the year 1922, SH Kelkar & Co is India’s oldest manufacturer and
supplier of Fragrance & Flavours (F&F). The company also exports its fragrances and
runs three manufacturing plants in India and one in the Netherlands. It commands a
market share of 20% in the fragrance industry catering to more than 3700 customers
across India. Its major clientele includes the likes of Godrej Consumer, ITC, GSK, HUL
and Vini. It ventured into flavours segment in 1992, leveraging its long relationship
with FMCG giants. Today, they sell flavours to dairy, bakery producers, beverages
and pharma companies such as Coca Cola, Britannia, Amul, Vicco and Vadilal. The
company also own brands like Cobra and Keva which is distributed through hundreds
of traders and re-sellers across India. Exports account for more than 40% of turnover
which is shipped across to 52 countries.
They have four manufacturing facilities, three of which are located in India and one
in The Netherlands, with a total installed manufacturing capacity of over 19,819 tons
annually.
Exhibit 5: Manufacturing facilities & installed capacities
Vapi, Gujarat Mumbai,
Maharashtra Raigad,
Maharashtra Barneveld, The Netherlands
Size Area (Acres) 18 11 37 One manufacturing facility with a musk and a multi-purpose unit Total capacity of 2 units : 1650 TPA Capacity utilisation : 77.2%
Fragrance (TPA) 2,064 4,599 10,342
Capacity Utilisation 35.8% 40.5% 44.2%
Flavours (TPA) - - 1164
Capacity Utilisation - - 34.0%
Source: Company Data, PL Research
Promoter and Management Bandwidth
Mr Ramesh Vinayak Vaze, MD – Mr Ramesh has been a veteran in the F&F industry
with more than four decades of experience He holds a degree of Bachelor's in
Science from University of Mumbai. He was appointed Managing Director of the
Company in August 2010.
Mr. Kedar Vaze, CEO - Mr. Kedar, a third generation founder-family member, has
been associated with Keva since 1st October 1996. He took over the role of Group
CEO in 2014, prior to which he worked within the Group in different roles of Chief
Technology Officer (CTO) and Group COO. In his capacity as COO, he managed all the
three businesses – Fragrance, Flavours & Aroma Ingredients. Being a proficient
Perfumer himself, Kedar Vaze has a number of F&F patents in his name. He has done
M.Sc., (Chemistry) from IIT Mumbai and subsequently attended Global Managers
Program at Stanford University, USA.
Exhibit 4: About the company
Employees 758
Products 9700+
Customers 4100+
Perfumers 12
Flavourists 2
Scientists 18
Creation & Development Centre
5
Manufacturing Locations 4
Credit rating CRISIL A+
Source: Company Data, PL Research
October 28, 2015 4
S H Kelkar & Co.
Investment Rationale
Strong play on the Fragrance industry in India
SH Kelkar is the largest manufacturer and supplier of fragrance products in India with
a market share of 20%. Established long-term market relationships and
comprehensive product portfolio, aids well for a long-term growth visibility.
SH Kelkar is in a bright spot considering experienced management, high entry
barriers and strong co-relation with Indian consumer growth.
Exhibit 6: SH Kelkar is amongst the top 3 players in the fragrance Industry in India
Givaudan26%
Firmenich21.20%
SH Kelkar
20.50%
Symrise10%
IFF7%
Goldfield
3%
Others
12%
Market share of Indian Fragrance Industry
Source: Company Data; PL Research
Favorable Industry dynamics and growth ready
The Indian F&F industry is estimated at ~Rs42bn in FY15. In the last four years, the
Indian fragrance and flavours markets have grown at 10.1% and 10.4%, respectively,
Increasing population, rising literacy levels, higher disposable income, changing
lifestyles etc. are the major drivers for growth of the F&F Industry.
SH Kelkar enjoys extensive library of product formulations created over the past nine
decades. Further, it enjoys long standing relationships with both FMCG companies
and key RM suppliers. With significant investments made in expanding capacities
over the past five years, we believe that SH Kelkar has a huge room for growth.
Urbanization, rising disposable incomes
and rise of modern retail offers favourable
business dynamics over the long term
October 28, 2015 5
S H Kelkar & Co.
Diverse customer base with negligible customer concentration
SH Kelkar has more than 4100 customers which include global corporate, domestic
FMCG giants and trade partners. This diverse clientele has ensured low customer
concentration with the largest customer contributing 2.9% of sales for FY15. Further,
SH Kelkar is full service supplier of 9700 F&F products and ingredients with a large
library of product formulations.
Exhibit 7: Most Indian brands use SH Kelkar’s products across F&F
Fragrance
Flavours Godrej Wipro Marico ITC
Coca-Cola ELan Vadilal DS Group
Vini Dabur HUL P&G
Abbott Amul Mapro Cantaur
J&J Emami Heinz TTK Healthcare
Parle Himalaya Dukes Concept
Nirma Oriflame RB VICCO
Britannia GSK Dinshaw's Sanofi
Himalaya Jyothy Bajaj Corp Reliance
Cream Bell MTR VICCO WeikFiELD
Source: Company data, PL research
Strong Entry Barriers limit competition
F&F Industry has high stringent regulatory environment with strict quality standards
for large players and requires high customer acquisition time (given that most
relationships between the suppliers and FMCG giants are long standing and are
difficult to penetrate). Thus, established players enjoy a large market share with the
top five accounting for over 70% of the business, dominated by four multinationals
and SH Kelkar.
Long term relationships with several
customers spanning over 15 years
October 28, 2015 6
S H Kelkar & Co.
Industry Dynamics
The Indian F&F industry (~Rs42bn market in FY15) includes more than 1,000
companies, ranging from MNCs, large Indian industrial houses to small-scale units
and regional manufacturers. The top five players in India controls almost 70% of the
Indian F&F market according to a Neilson market study on F&F. These MNCs have a
significant presence in India with strong established customer relationships with
FMCG companies.
Exhibit 8: Global F&F market is valued at US$26bn growing @4.8%
22
23
24
25
26
27
28
2013 2014 2015E 2016E
(US$
bn
)
Source: Company Data, PL Research
Exhibit 9: Indian F&F market is valued at Rs42bn growing @9.5 %
0
10
20
30
40
50
2013 2014 2015E 2016E
(Rs
m)
Source: Company Data, PL Research
Exhibit 10: Split of Indian F&F market
15.7 16.9 18.8 20.9
12.7 14.015.5
17.2
0.0
10.0
20.0
30.0
40.0
2011 2012 2013 2014
(Rs
bn)
Fragrance Mkt Size (Including blend) Flavour Mkt Size
Source: Company Data, PL Research
Exhibit 11: F&F Industry dominated by organized players (77% share)
27.8 29.3 32.0 35.5
6.58.8
9.710.1
0.0
10.0
20.0
30.0
40.0
50.0
2013 2014 2015E 2016E
(Rs
m)
Organised Unorganised
Source: Company Data, PL Research
October 28, 2015 7
S H Kelkar & Co.
Business Description
Their business primarily consists of two segments, i.e. fragrance and flavour.
Fragrance
SH Kelkar have a diverse portfolio of over 8,800 fragrance products, including
branded small packs and fragrance ingredients. Their products are essentially
fragrance compounds, which are complex fragrance compositions created by a
specialized team of perfumers by combining aromatic raw materials such as aroma
chemicals and essential oils. Their fragrance portfolio consists of products in the
following categories:
Personal Wash – Toilet soaps, Shower gels and Hand wash
Fabric Care – Detergent and Fabric softeners
Skin and Hair Care – Creams, Shampoos and Hair oils
Fine Fragrances – Deodorants and Perfumes
Home Care Products – Air care, Floor cleaners & Toilet cleaners
Fragrance and Flavour Blends – used by clients to make their products
Approximately 350 of their fragrance products manufactured at their Raigad plant
are sold to over 1,000 customers, including traders, resellers and small and medium
enterprises engaged in the manufacturing of soap, detergents and other home care
products in the smaller towns and villages of India. Their products are sold in smaller
quantities ranging from 25 grams to 500 grams each.
Flavours
SH Kelkar has a diverse portfolio of over 1100 flavour products which is used by
more than 400 customers, including manufacturers of beverages, confectionery,
dairy products, pharmaceuticals, oral hygiene products etc. Flavour products are
manufactured in liquid or encapsulated form and are categorized as natural, nature
identical or artificial flavours. Their flavour portfolio consists of:
Baked Goods – Biscuits, cookies and cakes
Dairy – Ice-cream, milk shakes, yoghurt and flavoured milk
Beverages – Tea, Juices, powdered drinks and Soda
Pharmaceuticals – syrups, powders, etc
SK Kelkar produced approximately 7,170
tons of fragrance and 434 tons of flavour in
the financial year 2015
October 28, 2015 8
S H Kelkar & Co.
Exhibit 12: Major FMCG products which use SH Kelkar’s products
Source: Company website, PL Research (For illustrative purpose only)
Established long term partnerships with key RM suppliers
SH Kelkar has an efficient mix of raw material sourcing, with 43% catered by
international suppliers. It has established relationships with some of the key
suppliers for over two decades. Top 10 suppliers accounted for ~35% of its RM
requirements for FY15. It has also implemented SAP ERP to manage operations for
planning, forecasting and monitoring replenishment system.
Exhibit 13: RM sourcing managed by efficient blend of outsourcing and captive production
Source: Company data, PL Research
Library of 1200+ Raw Material
International Suppliers: 43%
Sourcing from Indonesia, Germany,
Brazil, China, USA
Domestic
Suppliers: 57%
262 Indian
Suppliers
In House 250 fragrance ingredients
October 28, 2015 9
S H Kelkar & Co.
Financial Highlights
SH Kelkar revenues are growing @ 16% for the past four years
SH Kelkar’s financial performance has been robust with revenue and earnings CAGR
of 16.2% and 19.6%, respectively, over FY11-15 period. Cost of Material consumed
increased in FY15 primarily due to increase in volumes of RM and increase in average
price of certain natural RM resulting in margin pressure and dip in profitability over
FY14. However, situation is back to normal in Q1FY16 with pick-up in top-line and
margins back to steady state of 17%.
Exhibit 14: Steady sales growth over FY11-FY15 period
0.0%
5.0%
10.0%
15.0%
20.0%
-
2,000
4,000
6,000
8,000
10,000
FY1
1
FY1
2
FY1
3
FY1
4
FY1
5
Q1F
Y16
Sales (Rs m) EBITDA Margin (RHS)
Source:Company data, PL Research
Exhibit 15: Average PAT margins above 9% for past 3 years
0.0%
2.0%
4.0%
6.0%
8.0%
10.0%
12.0%
-
200
400
600
800
1,000
FY1
1
FY1
2
FY1
3
FY1
4
FY1
5
Q1
FY1
6
PAT (Rs m) PAT Margin (RHS)
Source: Company data, PL Research
Debt-free company post IPO, significant interest cost saving to accrue
Major parts of IPO proceeds (Rs2.1bn) are going to be utilized in retiring debt. This
shall save finance cost of almost Rs190m a year. At the end of Q1FY16, net debt
outstanding was Rs1.36bn.
Exhibit 16: Average finance cost of Rs190m for past five years
-
50
100
150
200
250
300
0
500
1000
1500
2000
2500
FY11 FY12 FY13 FY14 FY15
Debt (Rs m) Finance Cost (Rs m) (RHS)
Source: Company Data, PL Research
Revenue growth of 16% is split between
price hike (4-5%), Volume growth of old
portfolio (7-8%) and 3-4% addition of new
products
October 28, 2015 10
S H Kelkar & Co.
No significant capex required for growing 15% for the next five years
SH Kelkar has just completed its significant capex program over FY10-FY15 period incurring Rs2.15bn. With capacity utilizations hovering sub 40%, company does not
require any major capex for the next 5-7 years, barring certain product specific marginal capex. A debt-free balance sheet post issue and absence of capex in the medium term will result in generation of free cash flow, resulting in possibility of
higher dividend payout. This, in turn, is expected to result in an improvement in return ratios over the long run.
Exhibit 17: Major capex cycle behind aids strong cash generation over next five years
378
216
364
514
321
57
0
100
200
300
400
500
600
FY11 FY12 FY13 FY14 FY15 Q1FY16
(Rs
m)
Source: Company Data, PL Research
Working capital cycle looks stretched due to high RM inventories
Since SH Kelkar has product formulation library in excess of 9700, minimum amount of inventory of basic RM (1200+) needs to be maintained at all times. Due to the
business characteristics, there is no certainty with which a product demand can be forecasted. This apparently reflects as high working capital requirement for the business.
Exhibit 18: Average Inventory days of 136 for past 4 years
0
50
100
150
200
-
500
1,000
1,500
2,000
2,500
3,000
3,500
FY11 FY12 FY13 FY14 FY15
Inventory (Rs m) Inventory Days (RHS)
Source: Company Data, PL Research
October 28, 2015 11
S H Kelkar & Co.
Valuations and View
SH Kelkar & Co is India’s oldest and most renowned manufacturer and supplier of
Fragrance & Flavours (F&F). The company commands a market share of ~20% in the
fragrance industry (~size Rs23bn growing @10%) catering to more than 3700
customers across India. The fact that they are at a relative low market share of ~2%
in the flavours industry (~size Rs18.7bn growing @10%) where it caters to more than
400 customers offers higher scope for growth. In addition, favourable industry
dynamics and low capacity utilization of less than 40% bodes well for healthy growth
rates for SH Kelkar over the next few years. The IPO valuation of Rs26bn may look
expensive on FY15 valuations, which was as a result of one off aberration due to
spike in prices of certain raw materials in FY15. With a strong growth and improving
capacity utilisations over the next few years, we expect to see the margins to
increase and earnings grow steadily, making the stock an attractive buy in the IPO.
Considering factors such as quality management, high business entry barriers, no
Indian listed play in the F&F segment, limited equity offering and strong co-relation
with Indian consumer segment, we feel SH Kelkar is a portfolio stock and
recommend “Subscribe” for the long term.
Exhibit 19: Comparative Valuation
Currency Mcap
(bn)
Sales (m) PE Ratio (x) EV/Sales CY16E
(x)
RoE (%) EV/EBITDA (x) CY14-CY16E CAGR (%)
CY14 CY15E CY16E CY14 CY15E CY16E CY14 CY15E CY16E CY14 CY15E CY16E Sales EBITDA PAT
Givaudan CHF 14.9 4,404 4,359 4,538 28 23 21 3.5 16.5 18.3 19.1 15.1 15.0 14.5 2% 2% 12%
IFF USD 9.2 3,089 3,071 3,240 22 21 20 3.0 27.8 27.0 25.4 14.2 13.8 13.0 2% 5% 5%
Symrise EUR 7.4 2,120 2,619 2,867 40 26 24 3.0 15.6 19.0 19.1 20.0 14.8 13.7 16% 21% 22%
Source: Bloomberg, PL Research
October 28, 2015 12
S H Kelkar & Co.
Financials
Exhibit 20: Income Statement (Rs m)
Y/e March 2012 2013 2014 2015
Net Revenue 5,700 6,662 7,614 8,370
Operating Expenses 2,988 3,510 3,991 4,656
Gross Profit 2,712 3,152 3,622 3,714
Employee Cost 685 890 1,029 1,150
Other Expenses 983 1,082 1,222 1,371
EBITDA 1,044 1,180 1,370 1,193
Depr. & Amortization 173 173 188 293
Net Interest 277 217 175 186
Other Income 40 15 78 233
Profit before Tax 633 782 1,085 947
Total Tax 189 243 294 304
Profit after Tax 444 540 791 644
Ex-Od items / Min. Int./Profit in associates (32) 76 0 0
Adj. PAT 412 616 791 644
Adj. EPS* (Rs.) 3.1 4.6 6.0 4.8
Source: Company Data, PL Research * Historic EPS calculated on 133m shares outstanding
Exhibit 21: Balance Sheet (Rs m)
Y/e March 2012 2013 2014 2015
Shareholders’ Funds 3,762 4,244 4,810 5,103
Total Debt 2,138 1,331 1,837 2,136
Other Liabilities 115 671 154 151
Current Liabilities:
Trade Payables 483 737 879 1,016
Other Current Liabilities 548 733 739 738
Short Term Provisions 76 81 249 296
Total Liabilities 7,122 7,797 8,668 9,440
Net Fixed Assets 2,339 2,534 3,016 2,846
Investments 338 414 2 0
Other Assets 272 294 367 437
Current Assets:
Inventories 2,316 2,253 2,788 3,175
Trade receivables 1,309 1,721 1,794 1,947
Cash and cash equivalents 237 331 415 759
Short-term loans & advances 305 244 283 233
Other Current Assets 6 5 4 42
Total Assets 7,122 7,797 8,668 9,440
Source: Company Data, PL Research
October 28, 2015 13
S H Kelkar & Co.
Exhibit 22: Cash Flow (Rs m)
Y/e March 2012 2013 2014 2015
C/F from Operations 733 1,031 321 617
C/F from Investing (378) (333) (637) (173)
C/F from Financing (573) (607) 360 (75)
Inc. / Dec. in Cash (218) 91 43 369
Opening Cash 409 194 286 349
Closing Cash 194 286 349 718
Source: Company Data, PL Research
October 28, 2015 14
S H Kelkar & Co.
Annexure
Exhibit 23: Management team have an average experience in excess of two decades
Poul Spierings
Executive VP- Aroma Ingredients Exp of 27+ years
Makarand Patwardhan Vp - Operations & SCM
Exp of 29+ years Kedar Ramesh Vaze
Whole Time Director & Group CEO Exp of 19+ years
Pramod Devray Executive VP- Fragrance India
Exp of 38+ years
Indrajit Chatterjee Group CHRO
Exp of 20+ years
Tapas Majumdar Executive VP & CFO
Exp of 32+ years
Mohan Sapre Senior VP- International Fragrance
Exp of 30+ years
Anurag Yadava General Manager - Flavours
Exp of 22+ years
Source: Company Data, PL Research
October 28, 2015 15
S H Kelkar & Co.
Prabhudas Lilladher Pvt. Ltd.
3rd Floor, Sadhana House, 570, P. B. Marg, Worli, Mumbai-400 018, India
Tel: (91 22) 6632 2222 Fax: (91 22) 6632 2209
Rating Distribution of Research Coverage PL’s Recommendation Nomenclature
43.1% 44.1%
12.7%
0.0%0%
10%
20%
30%
40%
50%
BUY Accumulate Reduce Sell
% o
f To
tal C
ove
rage
BUY : Over 15% Outperformance to Sensex over 12-months
Accumulate : Outperformance to Sensex over 12-months
Reduce : Underperformance to Sensex over 12-months
Sell : Over 15% underperformance to Sensex over 12-months
Trading Buy : Over 10% absolute upside in 1-month
Trading Sell : Over 10% absolute decline in 1-month
Not Rated (NR) : No specific call on the stock
Under Review (UR) : Rating likely to change shortly
DISCLAIMER/DISCLOSURES
ANALYST CERTIFICATION
We/I, Mr. Nishna Biyani (BE, MBA-Finance), Mr. Keyur Pandya (Mcom, MBA-Finance), Research Analysts, authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report.
Terms & conditions and other disclosures:
Prabhudas Lilladher Pvt. Ltd, Mumbai, India (hereinafter referred to as “PL”) is engaged in the business of Stock Broking, Portfolio Manager, Depository Participant and distribution for third party financial products. PL is a subsidiary of Prabhudas Lilladher Advisory Services Pvt Ltd. which has its various subsidiaries engaged in business of commodity broking, investment banking, financial services (margin funding) and distribution of third party financial/other products, details in respect of which are available at www.plindia.com
This document has been prepared by the Research Division of PL and is meant for use by the recipient only as information and is not for circulation. This document is not to be reported or copied or made available to others without prior permission of PL. It should not be considered or taken as an offer to sell or a solicitation to buy or sell any security.
The information contained in this report has been obtained from sources that are considered to be reliable. However, PL has not independently verified the accuracy or completeness of the same. Neither PL nor any of its affiliates, its directors or its employees accepts any responsibility of whatsoever nature for the information, statements and opinion given, made available or expressed herein or for any omission therein.
Recipients of this report should be aware that past performance is not necessarily a guide to future performance and value of investments can go down as well. The suitability or otherwise of any investments will depend upon the recipient's particular circumstances and, in case of doubt, advice should be sought from an independent expert/advisor.
Either PL or its affiliates or its directors or its employees or its representatives or its clients or their relatives may have position(s), make market, act as principal or engage in transactions of securities of companies referred to in this report and they may have used the research material prior to publication.
PL may from time to time solicit or perform investment banking or other services for any company mentioned in this document.
PL is in the process of applying for certificate of registration as Research Analyst under Securities and Exchange Board of India (Research Analysts) Regulations, 2014
PL submits that no material disciplinary action has been taken on us by any Regulatory Authority impacting Equity Research Analysis activities.
PL or its research analysts or its associates or his relatives do not have any financial interest in the subject company.
PL or its research analysts or its associates or his relatives do not have actual/beneficial ownership of one per cent or more securities of the subject company at the end of the month immediately preceding the date of publication of the research report.
PL or its research analysts or its associates or his relatives do not have any material conflict of interest at the time of publication of the research report.
PL or its associates might have received compensation from the subject company in the past twelve months.
PL or its associates might have managed or co-managed public offering of securities for the subject company in the past twelve months or mandated by the subject company for any other assignment in the past twelve months.
PL or its associates might have received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months.
PL or its associates might have received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months
PL or its associates might have received any compensation or other benefits from the subject company or third party in connection with the research report.
PL encourages independence in research report preparation and strives to minimize conflict in preparation of research report. PL or its analysts did not receive any compensation or other benefits from the subject Company or third party in connection with the preparation of the research report. PL or its Research Analysts do not have any material conflict of interest at the time of publication of this report.
It is confirmed that Mr. Nishna Biyani (BE, MBA-Finance), Mr. Keyur Pandya (Mcom, MBA-Finance), Research Analysts of this report have not received any compensation from the companies mentioned in the report in the preceding twelve months
Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions.
The Research analysts for this report certifies that all of the views expressed in this report accurately reflect his or her personal views about the subject company or companies and its or their securities, and no part of his or her compensation was, is or will be, directly or indirectly related to specific recommendations or views expressed in this report.
The research analysts for this report has not served as an officer, director or employee of the subject company PL or its research analysts have not engaged in market making activity for the subject company
Our sales people, traders, and other professionals or affiliates may provide oral or written market commentary or trading strategies to our clients that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all o the foregoing, among other things, may give rise to real or potential conflicts of interest.
PL and its associates, their directors and employees may (a) from time to time, have a long or short position in, and buy or sell the securities of the subject company or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the subject company or act as an advisor or lender/borrower to the subject company or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions.
DISCLAIMER/DISCLOSURES (FOR US CLIENTS)
ANALYST CERTIFICATION
The research analysts, with respect to each issuer and its securities covered by them in this research report, certify that: All of the views expressed in this research report accurately reflect his or her or their personal views about all of the issuers and their securities; and No part of his or her or their compensation was, is or will be directly related to the specific recommendation or views expressed in this research report
Terms & conditions and other disclosures:
This research report is a product of Prabhudas Lilladher Pvt. Ltd., which is the employer of the research analyst(s) who has prepared the research report. The research analyst(s) preparing the research report is/are resident outside the United States (U.S.) and are not associated persons of any U.S. regulated broker-dealer and therefore the analyst(s) is/are not subject to supervision by a U.S. broker-dealer, and is/are not required to satisfy the regulatory licensing requirements of FINRA or required to otherwise comply with U.S. rules or regulations regarding, among other things, communications with a subject company, public appearances and trading securities held by a research analyst account.
This report is intended for distribution by Prabhudas Lilladher Pvt. Ltd. only to "Major Institutional Investors" as defined by Rule 15a-6(b)(4) of the U.S. Securities and Exchange Act, 1934 (the Exchange Act) and interpretations thereof by U.S. Securities and Exchange Commission (SEC) in reliance on Rule 15a 6(a)(2). If the recipient of this report is not a Major Institutional Investor as specified above, then it should not act upon this report and return the same to the sender. Further, this report may not be copied, duplicated and/or transmitted onward to any U.S. person, which is not the Major Institutional Investor.
In reliance on the exemption from registration provided by Rule 15a-6 of the Exchange Act and interpretations thereof by the SEC in order to conduct certain business with Major Institutional Investors, Prabhudas Lilladher Pvt. Ltd. has entered into an agreement with a U.S. registered broker-dealer, Marco Polo Securities Inc. ("Marco Polo").
Transactions in securities discussed in this research report should be effected through Marco Polo or another U.S. registered broker dealer.